Gene · 4627
Papers4,242
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 4,242
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Resolving the gene expression maps of human first-trimester chorionic villi with spatial transcriptome. | Front Cell Dev Biol | 2022 | 36561369 | PubTator, text mining | PubMed |
| EBV Association with Lymphomas and Carcinomas in the Oral Compartment. | Viruses | 2022 | 36560704 | PubTator, text mining | PubMed |
| Particle Therapy: Clinical Applications and Biological Effects. | Life (Basel) | 2022 | 36556436 | PubTator, text mining | PubMed |
| Targeting TLR2/Rac1/cdc42/JNK Pathway to Reveal That Ruxolitinib Promotes Thrombocytopoiesis. | Int J Mol Sci | 2022 | 36555781 | PubTator, text mining | PubMed |
| Spectrum of Genes for Non-GJB2-Related Non-Syndromic Hearing Loss in the Russian Population Revealed by a Targeted Deafness Gene Panel. | Int J Mol Sci | 2022 | 36555390 | PubTator, text mining | PubMed |
| Successful Eltrombopag Therapy in a Child with MYH9-Related Inherited Thrombocytopenia. | Children (Basel) | 2022 | 36553283 | PubTator, text mining | PubMed |
| Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG. | Cells | 2022 | 36552831 | PubTator, text mining | PubMed |
| Cellular features of localized microenvironments in human meniscal degeneration: a single-cell transcriptomic study. | Elife | 2022 | 36548025 | PubTator, text mining | PubMed |
| NAFLD and HBV interplay - related mechanisms underlying liver disease progression. | Front Immunol | 2022 | 36544761 | PubTator, text mining | PubMed |
| Cellular and Functional Biomarkers of Renal Injury and Disease. | Curr Opin Toxicol | 2022 | 36540379 | PubTator, text mining | PubMed |
| Novel THPO variant in hereditary thrombocytopenia: A potential candidate variant for predisposition to myeloid neoplasm. | PLoS One | 2022 | 36534659 | PubTator, text mining | PubMed |
| Psychological burden predicts new-onset diabetes in men: A longitudinal observational study in the Fukushima Health Management Survey after the Great East Japan earthquake. | Front Endocrinol (Lausanne) | 2022 | 36531489 | PubTator, text mining | PubMed |
| "CHildren with Inherited Platelet disorders Surveillance" (CHIPS) retrospective and prospective observational cohort study by Italian Association of Pediatric Hematology and Oncology (AIEOP). | Front Pediatr | 2022 | 36507135 | PubTator, text mining | PubMed |
| Crosstalk of angiogenesis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in colorectal adenocarcinoma. | Front Immunol | 2022 | 36505481 | PubTator, text mining | PubMed |
| Development of Epstein-Barr virus-associated gastric cancer: Infection, inflammation, and oncogenesis. | World J Gastroenterol | 2022 | 36504553 | PubTator, text mining | PubMed |
| Tumor-Derived Small Extracellular Vesicles Involved in Breast Cancer Progression and Drug Resistance. | Int J Mol Sci | 2022 | 36499561 | PubTator, text mining | PubMed |
| Urgency and necessity of Epstein-Barr virus prophylactic vaccines. | NPJ Vaccines | 2022 | 36494369 | PubTator, text mining | PubMed |
| ToMExO: A probabilistic tree-structured model for cancer progression. | PLoS Comput Biol | 2022 | 36469540 | PubTator, text mining | PubMed |
| Tacrolimus pharmacokinetics in pediatric nephrotic syndrome: A combination of population pharmacokinetic modelling and machine learning approaches to improve individual prediction. | Front Pharmacol | 2022 | 36457704 | PubTator, text mining | PubMed |
| The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer. | Nat Genet | 2022 | 36456881 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4627/papers?page=39